Viewing StudyNCT00390858



Ignite Creation Date: 2024-05-05 @ 5:09 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00390858
Status: COMPLETED
Last Update Posted: 2017-03-20
First Post: 2006-10-18

Brief Title: A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Pediatric Rare Anemia
Transfusional Iron Overload
β-thalassemia Major
Keywords:
Name View
β-thalassemia major View
iron overload View
deferasirox View
pediatric rare anemia View